Trial site
Huashan Hospital Affiliated to Fudan University
- 28running trials
- 25closed trials
The trials here
What the 53 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Psoriasis4 trials
- Hepatitis B3 trials
- Liver and biliary tract cancer3 trials
- Lupus (SLE)3 trials
- Myasthenia gravis3 trials
- Alopecia areata2 trials
- Alzheimer disease2 trials
- Atopic dermatitis (eczema)2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Glioblastoma2 trials
- Myeloproliferative neoplasms2 trials
- and 26 more
- Phase
- Phase 318 trials
- Phase 113 trials
- Phase 28 trials
- Phase 42 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed21 trials
- Recruiting13 trials
- Active, not recruiting9 trials
- Not yet recruiting5 trials
- Terminated2 trials
- Withdrawn2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Huashan Hospital5 trials
- BeiGene4 trials
- argenx2 trials
- Beijing Continent Pharmaceutical Co, Ltd.2 trials
- Beijing InnoCare Pharma Tech Co., Ltd.2 trials
- and 35 more
Running trials
Recruiting
Recruiting
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Not yet recruiting
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
Not yet recruiting
A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria
Not yet recruiting
Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research
Recruiting
Recruiting
A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
Recruiting
Recruiting
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Recruiting
Recruiting
Research on Wireless Brain Implant System for General Control of External Devices
Active, not recruiting
Active, not recruiting
Active, not recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Recruiting
Active, not recruiting
Recruiting
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Enrolling by invitation
Recruiting
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Active, not recruiting
Active, not recruiting
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
Active, not recruiting
Recruiting
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myasthenia gravis2 recruiting
- Pancreatic cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- ALS (motor neurone disease)1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Childhood cancers1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Colorectal cancer1 recruiting
- Depression1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lupus (SLE)1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Rheumatoid arthritis1 recruiting
- Sjögren's disease1 recruiting
- Spinal cord injury1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Tuberculosis1 recruiting
Closed trials
Withdrawn
Completed
Completed
Withdrawn
Completed
A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants
Completed
Completed
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Completed
Completed
Completed
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Completed
SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects
Completed
Completed
Completed
Terminated
A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors
Completed
Completed
Terminated
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Completed
Completed
Completed
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
Completed
Completed
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Completed
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Site data: ClinicalTrials.govUpdated 18 Nov 2026